380 related articles for article (PubMed ID: 3937410)
1. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
[No Abstract] [Full Text] [Related]
2. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
[TBL] [Abstract][Full Text] [Related]
3. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
Moffat EH; Giddings JC; Bloom AL
Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
[TBL] [Abstract][Full Text] [Related]
4. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
Fukui H; Takase T
Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
[No Abstract] [Full Text] [Related]
5. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
[No Abstract] [Full Text] [Related]
6. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
Yorde LD; Yorde DE; Sasse EA; Hussey CV
Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
9. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
Fukui H
Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
[No Abstract] [Full Text] [Related]
10. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
11. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
12. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
13. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
14. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
[TBL] [Abstract][Full Text] [Related]
15. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
16. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
Warrier AI; Lusher JM
J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
[TBL] [Abstract][Full Text] [Related]
17. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
Mannucci PM; Canciani MT; Rota L; Donovan BS
Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
[TBL] [Abstract][Full Text] [Related]
18. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
Marwick C
JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
[No Abstract] [Full Text] [Related]
19. Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease.
Lethagen S; Ostergaard H; Nilsson IM
Scand J Haematol; 1986 Nov; 37(5):448-53. PubMed ID: 3101169
[TBL] [Abstract][Full Text] [Related]
20. [Desmopressin in hemophilia A and Von Willebrand's disease].
Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
